@article{article, title = {{Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study}}, publisher = {{Springer Science and Business Media LLC}}, url = {{}}, year = {{2021}}, month = {{6}}, author = {{Pennington B and Alshreef A and Flight L and Metry A and Poku E and Hykin P and Sivaprasad S and Prevost AT and Vasconcelos JC and Murphy C and Kelly J et al}}, doi = {{10.1007/s40273-021-01057-y}}, journal = {{PharmacoEconomics}}, note = {{Accessed on 2025/04/10}}}